As Canadian cannabis firms continue expansion plans on the international stage, a group of panelists discusses what is needed to continue this momentum.

During the Lift & Co. (TSXV:LIFT) cannabis expo in Vancouver, investors got a chance to catch up on the state of the international cannabis space thanks to a talk with Rick Brar, at the time CEO of Zenabis (TSXV:ZENA), Stephen Murphy, managing director Prohibition Partners, Guillermo Delmonte, president of international division with Organigram (TSXV:OGI) and Jorge Rubio Escalona, a representative from the Mexican federal government.

The panel agreed Canadian firms have mounted an assertive strategy for expansion across the globe as more countries begin moving forward with cannabis policy.


Cannabis - Will The Fortune 500 Join The Party?

Our Exclusive FREE Report Contains Information You NEED To Know About Cannabis Stock Investing!

“Canadian companies have benefited from public markets and those public markets has allowed them to I suppose be quite aggressive in their market entry,” Murphy told the Investing News Network in a video interview following his panel.

During the panel, Brar explained public market capital inflow comes to Canada and then gets deployed on the new regions legalizing cannabis.

He added the US is the other country at the center of the capital inflow.

The former Zenabis CEO recognized despite several interests all across the globe from Canadian LPs, the “primary capital inflow” is still going to head to Canada and the US.

According to Brar Zenabis is focused, internationally, in the UK alongside the rest of Europe and Latin America.

Delmonte explained when a Canadian firm prepares for an international expansion, the company has to consider multiple factors such as the political situation and economic needs and pressures from that country.

State of international regulations and challenges of different policy between countries

When asked what the current perspective from the different regulations or policies among countries, Murphy explained it’s a very “disjointed” path for Canadian firms to try and navigate.


Cannabis - Will The Fortune 500 Join The Party?

Our Exclusive FREE Report Contains Information You NEED To Know About Cannabis Stock Investing!

Despite this frustration that, according to Murphy, can become expensive as well, the researcher said the United Nations and the European Union are working on creating an “international regulation guideline for medical cannabis.”

Murphy said there isn’t as much pressure from the global organizations to create these guidelines due to the lack of involvement from the US.

Brar asked for the audience to understand the process of legalization is going to take more time than expected on the international stage.

Canada’s position and race for cheapest growth rates

The panelists discussed how, as more markets begin legalizing, new countries with better conditions for the growth of cannabis will become available.

Murphy explained he has seen markets that offer extremely low costs of production, but admitted that option will matter as long companies know who exactly the end-consumer will be.

Both Delmonte and Brar refused the notion international growing of cannabis would outpace Canada anytime soon.

The Organigram executive said he worries about challenges from a lack of experience.

“Canada will remain strongly positioned as one of the global leaders in growing and a hub for R&D, a hub for oil, a hub for all of the ingredients and all of the science,” Brar said.

Murphy explained in the race among Canadian firms to enter international markets, the real determination of winners will be “getting uptake.”

“It’s about those that can not only secure access into that market but all of the surrounding services and complimentary add-ons regarding education, information, patient access and patient data, that really gives the competitive edge to LPs when they enter the market,” Murphy said.

Don’t forget to follow us @INN_Cannabis for real-time news updates!

Securities Disclosure: I, Bryan Mc Govern, hold no direct investment interest in any company mentioned in this article.

Editorial Disclosure: The Investing News Network does not guarantee the accuracy or thoroughness of the information reported in the interviews it conducts. The opinions expressed in these interviews do not reflect the opinions of the Investing News Network and do not constitute investment advice. All readers are encouraged to perform their own due diligence.


Cannabis - Will The Fortune 500 Join The Party?

Our Exclusive FREE Report Contains Information You NEED To Know About Cannabis Stock Investing!

Halper Sadeh LLP, a global investor rights law firm, is investigating whether the sale of Harvest Health & Recreation Inc. (OTCQX: HRVSF) to Trulieve Cannabis Corp. is fair to Harvest Health shareholders. Under the terms of the agreement, Harvest shareholders will receive 0.1170 of a subordinate voting share of Trulieve for each Harvest subordinate voting share (or equivalent) held.

Halper Sadeh encourages Harvest Health shareholders to click here to learn more about their legal rights and options or contact Daniel Sadeh or Zachary Halper at (212) 763-0060 or or .

Keep reading... Show less

Spyder Cannabis Inc. (TSXV: SPDR) (“Spyder” or the “Company”), an established Canadian cannabis and vape retailer, announced today the appointment of Cameron Wickham as a Director, Chief Executive Officer and Corporate Secretary of the Company and Ankit Gosain as Chief Financial Officer of the Company, effective May 7, 2021.

Daniel Pelchovitz, the Company’s former Chief Executive Officer, will continue with Spyder as a Director of the Company and as Chief Executive Officer of Spyder Cannabis Subco Inc., the Company’s Alcohol and Gaming Commission of Ontario (AGCO)-licensed, wholly-owned subsidiary that currently operates a cannabis dispensary in Niagara Falls, Ontario and has submitted two additional Retail Store Authorizations to the AGCO, and The Green Spyder Inc., the Company’s Alberta Gaming, Liquor & Cannabis (AGLC)-licensed, wholly-owned subsidiary that currently operates a cannabis dispensary in Calgary, Alberta.

Keep reading... Show less

Curaleaf Holdings, Inc. (CSE: CURA) (OTCQX: CURLF) (“Curaleaf” or the “Company”) , a leading international provider of consumer products in cannabis, today reported its financial and operating results for the first quarter ended March 31, 2021 . All financial information is provided in U.S. dollars unless otherwise indicated.

1Q 2021 Financial Highlights (Unaudited)

Keep reading... Show less

WeissLaw LLP is investigating possible breaches of fiduciary duty and other violations of law by the board of directors of Harvest Health & Recreation Inc. (“Harvest” or the “Company”) (OTC: HRVSF) in connection with the proposed acquisition of the Company by Trulieve Cannabis Corp. (“Trulieve”) (OTC: TCNNF). Under the terms of the merger agreement, Harvest shareholders will receive 0.1170 shares of Trulieve common stock for each Harvest share that they own, representing implied per-share merger consideration of approximately $4.79 based upon Trulieve’s May 7, 2021 closing price of $40.92 . Upon consummation of the transaction, current Harvest shareholders will own only 26.7% of the issued and outstanding pro forma Trulieve shares.

Keep reading... Show less

Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) (“Cronos Group” or the “Company”), an innovative global cannabinoid company, today announced that Mike Gorenstein, Executive Chairman, will speak at Canaccord Genuity’s 5th Annual Global Cannabis Conference on Tuesday, May 11, 2021 at 2:30 p.m. EDT.

Participants may access a live webcast of the presentation by going to the Upcoming Events page at . A replay will be made available shortly following the live presentation.

Keep reading... Show less